Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ZhiYu Li

Showing results (541-550 of 583) with videos related to

Pageof 59
Sort By:
Frontiers in Oncology|June 21, 2024
Treatment experience for different risk groups of Kaposiform hemangioendotheliomaMiaomiao Li, Xusheng Wang, Rosalind Kieran, et al.
Oncotarget|November 19, 2011
ARID2: a new tumor suppressor gene in hepatocellular carcinomaHong Zhao, Jian Wang, Yongqing Han, et al.
Journal of Medicinal Chemistry|August 22, 2003
Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinasesCassandra L Woodard, Zhiyu Li, April K Kathcart, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2022
The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary AdenomaChenxing Ji, Wen Xu, Hong Ding, et al.
Journal of Medicinal Chemistry|January 24, 2025
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue DegradersYanqing Zhang, Wenjing Liu, Chao Tong, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 2, 2025
Safety and immunogenicity of hepatitis E vaccine in compensated liver cirrhosis with chronic hepatitis BXuejiao Liao, Dapeng Li, Yingying Su, et al.
Journal of Medicinal Chemistry|October 23, 2023
Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung CancerTizhi Wu, Bin Yu, Yifan Xu, et al.
European Journal of Medicinal Chemistry|November 22, 2025
Design, synthesis, and pharmacological evaluation of novel isoindoline-based HPK1 degradersZhisheng Zhang, Xuan Zhang, Tizhi Wu, et al.
Oncology Letters|April 17, 2023
Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysisKexun Li, Kunyi Du, Kun Liu, et al.
Journal of Hepatology|July 16, 2025
Enhanced surveillance, subtyping, and host adaptation analysis reveal genotype-wide zoonotic potential of rat hepatitis E virusKelvin Hon-Yin Lo, Siu-Fung Stanley Ho, Estie Hon-Kiu Shun, et al.
Pageof 59

Showing results (541-550 of 583) with videos related to

Sort By:
Pageof 59
Frontiers in Oncology|June 21, 2024
Treatment experience for different risk groups of Kaposiform hemangioendotheliomaMiaomiao Li, Xusheng Wang, Rosalind Kieran, et al.
Oncotarget|November 19, 2011
ARID2: a new tumor suppressor gene in hepatocellular carcinomaHong Zhao, Jian Wang, Yongqing Han, et al.
Journal of Medicinal Chemistry|August 22, 2003
Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinasesCassandra L Woodard, Zhiyu Li, April K Kathcart, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2022
The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary AdenomaChenxing Ji, Wen Xu, Hong Ding, et al.
Journal of Medicinal Chemistry|January 24, 2025
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue DegradersYanqing Zhang, Wenjing Liu, Chao Tong, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 2, 2025
Safety and immunogenicity of hepatitis E vaccine in compensated liver cirrhosis with chronic hepatitis BXuejiao Liao, Dapeng Li, Yingying Su, et al.
Journal of Medicinal Chemistry|October 23, 2023
Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung CancerTizhi Wu, Bin Yu, Yifan Xu, et al.
European Journal of Medicinal Chemistry|November 22, 2025
Design, synthesis, and pharmacological evaluation of novel isoindoline-based HPK1 degradersZhisheng Zhang, Xuan Zhang, Tizhi Wu, et al.
Oncology Letters|April 17, 2023
Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysisKexun Li, Kunyi Du, Kun Liu, et al.
Journal of Hepatology|July 16, 2025
Enhanced surveillance, subtyping, and host adaptation analysis reveal genotype-wide zoonotic potential of rat hepatitis E virusKelvin Hon-Yin Lo, Siu-Fung Stanley Ho, Estie Hon-Kiu Shun, et al.
Pageof 59